EClinCloud AI Platform Supports More Than 1,100 Clinical Trials
EClinCloud said in an announcement that its clinical research platform now supports more than 1,100 trials for over 300 sponsor and research organizations. The platform serves more than 20,000 users across more than 10 countries and regions.
The platform combines electronic data capture, trial supply management, clinical outcome assessments, clinical trial management, resource management, electronic trial records, independent review services, and online learning through a shared data model and workflow engine.
Its role based AI agents parse clinical protocols and assist with study configuration. EClinCloud reports that this reduces study build effort by about 60 percent, while its medical optical character recognition system captures source data with accuracy above 95 percent across more than 1,000 form types.
EClinCloud launched an embedded AI agent and a new independent review committee platform in 2026. Its AI management system holds ISO/IEC 42001:2023 certification, alongside ISO 27001 and ISO 27701 certifications.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 21 Epic Explores AI Agents for Routine Patient Visits Oct 21 Russia Drops AI VPN Blocking Target From National Plan Oct 21 FDA and MHRA outline faster rules for generative AI medical devices Oct 20 Sunlight AI Raises $17.4 Million and Acquires Bradford Medical Associates Oct 20 Georgia Tech instructions reduce chatbot agreement with delusions by 74%Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
AstraZeneca and Oracle Partner on AI for Clinical Trials
AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034
Suvoda Updates Clinical Trial Platform With AI and Unified Access
CureMD Earns ISO/IEC 42001 Certification for AI Management
Study Tracks 270 Million Clinical AI Queries on OpenEvidence
Daily AI Brief: the AI news that matters, in your inbox.